Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia

Jan A. Burger, Mariela Sivina, Nitin Jain, Ekaterina Kim, Tapan Kadia, Zeev Estrov, Graciela M. Nogueras-Gonzalez, Xuelin Huang, Jeffrey Jorgensen, Jianling Li, Mei Cheng, Fong Clow, Maro Ohanian, Michael Andreeff, Thomas Mathew, Philip Thompson, Hagop Kantarjian, Susan O'Brien, William G. Wierda, Alessandra FerrajoliMichael J. Keating

Research output: Contribution to journalArticlepeer-review

168 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry